Pharmacogenomics
Evidence required to demonstrate clinical utility of pharmacogenetic testing: the debate continues
Gillis NK & Innocenti F Clin Pharmacol Ther 2014 Dec;96(6):655-7
Gillis NK & Innocenti F Clin Pharmacol Ther 2014 Dec;96(6):655-7
Meaningful use of pharmacogenetics
M J Ratain and J A Johnson Clinical Pharmacology & Therapeutics (2014); 96 6, 650–652.
M J Ratain and J A Johnson Clinical Pharmacology & Therapeutics (2014); 96 6, 650–652.
Useless until proven effective: The clinical utility of preemptive pharmacogenetic testing
A C J W Janssens and P A Deverka Clinical Pharmacology & Therapeutics (2014); 96 6, 652–654.
A C J W Janssens and P A Deverka Clinical Pharmacology & Therapeutics (2014); 96 6, 652–654.
No hay comentarios:
Publicar un comentario